0,879  0,002  Alcohol oxidase inhibitor
0,834  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,779  0,003  5 Hydroxytryptamine release inhibitor
0,778  0,005  Aldehyde oxidase inhibitor
0,748  0,008  GST A substrate
0,721  0,002  GABA C receptor agonist
0,696  0,005  Histamine release inhibitor
0,692  0,002  Porphobilinogen synthase inhibitor
0,648  0,001  Aconitate hydratase inhibitor
0,650  0,005  Ulceration
0,641  0,004  FMO1 substrate
0,635  0,005  Superoxide dismutase inhibitor
0,624  0,016  Cholesterol antagonist
0,579  0,010  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,573  0,011  GABA C receptor rho-3 antagonist
0,565  0,004  Acaricide
0,555  0,002  Ferrochelatase inhibitor
0,555  0,002  Excitatory amino acid transporter EAAC1 inhibitor
0,573  0,032  Cyclophilin D inhibitor
0,573  0,032  Antidiabetic
0,542  0,007  Peroxidase inhibitor
0,542  0,015  Calcium channel L-type activator
0,532  0,007  Carcinogenic, group 3
0,527  0,002  Triose-phosphate isomerase inhibitor
0,522  0,004  5 Hydroxytryptamine uptake stimulant
0,509  0,003  Succinate dehydrogenase inhibitor
0,510  0,004  UGT2B1 substrate
0,523  0,017  Cardiovascular analeptic
0,527  0,025  Antipruritic, allergic
0,524  0,027  Atherosclerosis treatment
0,507  0,016  Antidiabetic (type 2)
0,515  0,025  Vasodilator, peripheral
0,519  0,030  Teratogen
0,490  0,005  FMO3 substrate
0,494  0,012  UDP-glucuronosyltransferase substrate
0,502  0,022  CTGF expression inhibitor
0,484  0,004  Gout treatment
0,500  0,026  Antihypercholesterolemic
0,475  0,003  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,475  0,005  Renal failure treatment
0,491  0,021  UGT1A9 substrate
0,481  0,011  Antihypoxic
0,498  0,029  Stroke treatment
0,500  0,031  Embryotoxic
0,473  0,005  GST M1-1 substrate
0,478  0,014  Antihypertriglyceridemic
0,475  0,012  Antimutagenic
0,474  0,015  UGT1A6 substrate
0,469  0,010  Anesthetic general
0,484  0,025  Radioprotector
0,481  0,024  Sensitization
0,462  0,007  Antiparkinsonian, rigidity relieving
0,483  0,030  5 Hydroxytryptamine release stimulant
0,479  0,031  Respiratory analeptic
0,453  0,013  Interleukin agonist
0,450  0,010  Flavin-containing monooxygenase substrate
0,456  0,019  UGT2B4 substrate
0,440  0,004  UDP-glucose 4-epimerase inhibitor
0,461  0,027  Antipsoriatic
0,436  0,010  Antiseptic
0,433  0,007  Protein-tyrosine phosphatase inhibitor
0,468  0,043  CYP2C9 substrate
0,442  0,017  Eye irritation, high
0,447  0,029  Lipoprotein disorders treatment
0,439  0,021  Antipyretic
0,429  0,016  Calcium channel activator
0,418  0,006  Tyrosine 3 hydroxylase inhibitor
0,417  0,008  Pneumotoxic
0,414  0,004  NADH dehydrogenase inhibitor
0,464  0,057  TNF expression inhibitor
0,429  0,023  Hypoglycemic
0,408  0,003  Glutamate decarboxylase inhibitor
0,424  0,021  Radiosensitizer
0,406  0,004  Glutamate dehydrogenase inhibitor
0,409  0,008  GST P1-1 substrate
0,402  0,004  Histidine decarboxylase inhibitor
0,406  0,010  Mcl-1 antagonist
0,448  0,058  Antibacterial
0,393  0,004  Uric acid excretion stimulant
0,391  0,004  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,462  0,077  Caspase 9 stimulant
0,419  0,038  Hepatic disorders treatment
0,412  0,031  Carcinogenic
0,403  0,022  Acute neurologic disorders treatment
0,395  0,016  UGT1A4 substrate
0,394  0,017  Skin irritative effect
0,380  0,002  Biliverdin reductase inhibitor
0,391  0,018  Abortion inducer
0,407  0,036  Analeptic
0,408  0,038  Antihypertensive
0,403  0,034  Vasodilator, coronary
0,379  0,010  Urolithiasis treatment
0,368  0,002  Fumarate hydratase inhibitor
0,395  0,031  Mutagenic
0,374  0,010  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,368  0,004  Antispirochetal
0,386  0,023  DNA synthesis inhibitor
0,366  0,007  Gastrin inhibitor
0,362  0,003  Phenylalanine 4-hydroxylase inhibitor
0,364  0,006  Cystathionine beta-synthase inhibitor
0,361  0,003  Creatine kinase inhibitor
0,374  0,017  Dual specificity phosphatase 3 inhibitor
0,362  0,004  Adenylate kinase inhibitor
0,360  0,003  NAT1 substrate
0,362  0,006  Carcinogenic, group 1
0,384  0,031  Renal disease treatment
0,369  0,018  Dual specificity phosphatase inhibitor
0,376  0,026  Sodium/bile acid cotransporter inhibitor
0,352  0,004  Prostaglandin E2 antagonist
0,360  0,014  Antipruritic, non-allergic
0,358  0,014  Phospholipase C inhibitor
0,352  0,010  Antiparkinsonian, tremor relieving
0,385  0,046  ICAM1 expression inhibitor
0,360  0,021  UGT1A1 substrate
0,346  0,008  Protein-tyrosine phosphatase 1B inhibitor
0,368  0,031  Hypolipemic
0,364  0,030  Insulysin inhibitor
0,363  0,029  Vascular (periferal) disease treatment
0,340  0,008  Aldehyde dehydrogenase inhibitor
0,346  0,016  Antiacne
0,333  0,004  Electrolyte absorption antagonist
0,334  0,006  Carbonic anhydrase XV inhibitor
0,332  0,004  GABA C receptor antagonist
0,330  0,004  NAT2 substrate
0,334  0,007  UGT2B9 substrate
0,360  0,035  Cardiodepressant
0,363  0,039  Cytostatic
0,371  0,049  AR expression inhibitor
0,329  0,009  Antihyperlipoproteinemic
0,339  0,021  Antiviral (Influenza)
0,369  0,058  Antithrombotic
0,328  0,019  VCAM1 expression inhibitor
0,348  0,039  Platelet antagonist
0,333  0,026  RNA-directed DNA polymerase inhibitor
0,333  0,028  Wound healing agent
0,318  0,015  Genotoxic
0,340  0,037  Pyruvate kinase inhibitor
0,321  0,020  DNA methyltransferase I inhibitor
0,304  0,003  GABA C receptor rho-1 antagonist
0,422  0,126  Antiinflammatory
0,323  0,027  Platelet adhesion inhibitor
0,297  0,002  Antidote, mercury
0,299  0,005  Arylamine N-Acetyltransferase substrate
0,296  0,003  GABA aminotransferase inhibitor
0,299  0,009  SULT1A3 substrate
0,308  0,020  Lipocortins synthesis antagonist
0,334  0,047  NOS2 expression inhibitor
0,365  0,079  Immunosuppressant
0,291  0,004  Keratolytic
0,296  0,011  Hexokinase inhibitor
0,309  0,025  DNA methylase inhibitor
0,290  0,006  Phosphofructokinase-1 inhibitor
0,299  0,017  UGT2B15 substrate
0,330  0,049  Chemoprotective
0,306  0,025  UGT2B7 substrate
0,291  0,011  Aldehyde oxidase substrate
0,286  0,006  Mannose-6-phosphate isomerase inhibitor
0,293  0,014  Antidiabetic (type 1)
0,299  0,021  UGT1A3 substrate
0,282  0,007  GABA C receptor rho-2 antagonist
0,280  0,004  Argininosuccinate synthase inhibitor
0,279  0,004  Antirickettsial
0,295  0,021  Interferon gamma antagonist
0,303  0,029  Antihypotensive
0,332  0,058  Spasmolytic
0,285  0,016  Phospholipase A2 inhibitor
0,275  0,006  Alcohol dehydrogenase inhibitor
0,283  0,014  M17 leucyl aminopeptidase inhibitor
0,315  0,046  Transcription factor STAT3 inhibitor
0,288  0,020  Prostate disorders treatment
0,286  0,019  Insulin sensitizer
0,275  0,010  Expectorant
0,269  0,005  Prostaglandin antagonist
0,303  0,041  Cyclic AMP phosphodiesterase inhibitor
0,265  0,004  NMDA receptor agonist
0,265  0,003  GST T1-1 substrate
0,322  0,060  Interleukin 2 agonist
0,269  0,007  Carbonic anhydrase III inhibitor
0,310  0,050  Transcription factor STAT inhibitor
0,277  0,017  3C-like protease (Human coronavirus) inhibitor
0,278  0,022  Amylase inhibitor
0,261  0,004  HIV-1 integrase (Overall Integration) inhibitor
0,325  0,070  Apoptosis antagonist
0,260  0,005  Mucolytic
0,260  0,006  Antithrombocytopenic
0,261  0,008  Choleretic
0,263  0,011  Xanthine oxidase inhibitor
0,271  0,021  Nitric-oxide synthase stimulant
0,311  0,062  CYP2C19 substrate
0,293  0,045  Antiulcerative
0,253  0,007  Raynaud's phenomenon treatment
0,314  0,068  NOS3 expression inhibitor
0,249  0,004  DOPA decarboxylase inhibitor
0,259  0,014  Cell wall synthesis inhibitor
0,334  0,091  CYP2C9 inhibitor
0,255  0,012  Aminopeptidase B inhibitor
0,305  0,063  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,339  0,098  CYP2C19 inhibitor
0,250  0,009  Catalase inhibitor
0,256  0,015  Antianemic
0,244  0,003  Purinergic P2Y14 antagonist
0,244  0,004  CD45 antagonist
0,323  0,085  Transcription factor NF kappa B inhibitor
0,251  0,013  UGT2B10 substrate
0,257  0,022  Antidote
0,240  0,006  TRPA1 agonist
0,236  0,005  Prostaglandin EP2 antagonist
0,255  0,024  Antiviral (Influenza A)
0,258  0,027  Cytidine deaminase inhibitor
0,233  0,004  Acyl-CoA dehydrogenase inhibitor
0,298  0,069  CYP1A2 substrate
0,230  0,002  Retinoid X beta receptor agonist
0,256  0,030  Antiviral (West Nile virus)
0,259  0,034  Neurotrophic factor enhancer
0,229  0,004  Heat shock protein 70 antagonist
0,346  0,122  Antiarthritic
0,229  0,006  Carcinogenic, group 2A
0,232  0,012  SULT1A1 substrate
0,236  0,017  ATPase inhibitor
0,226  0,007  Folate antagonist
0,246  0,028  Protein kinase stimulant
0,276  0,058  Antiglaucomic
0,279  0,061  Antidiabetic symptomatic
0,312  0,095  CYP3A4 substrate
0,229  0,012  Arachidonic acid antagonist
0,296  0,079  Immunostimulant
0,277  0,061  Proliferative diseases treatment
0,225  0,009  Antiprotozoal (Babesia)
0,240  0,025  Monophenol monooxygenase inhibitor
0,217  0,002  Ca2+-transporting ATPase inhibitor
0,230  0,016  Carcinogenic, group 2B
0,218  0,004  Nicotinic acid receptor 2 agonist
0,275  0,062  Antineoplastic (liver cancer)
0,217  0,004  Protein kinase C eta inhibitor
0,216  0,003  Antifungal (Pneumocystis)
0,231  0,020  Cholesterol synthesis inhibitor
0,252  0,042  Non-steroidal antiinflammatory agent
0,216  0,006  Sphingosine 1-phosphate receptor 5 antagonist
0,218  0,009  Antihelmintic (Fasciola)
0,283  0,074  Hypoxia-inducible factor 1 alpha inhibitor
0,220  0,011  Antineoplastic, alkylator
0,213  0,005  Leukotriene synthesis inhibitor
0,219  0,011  Potassium channel (Ca-activated) activator
0,218  0,011  Carbonic anhydrase VI inhibitor
0,286  0,079  Lipoxygenase inhibitor
0,262  0,055  Antiparasitic
0,228  0,021  Glutathione S-transferase substrate
0,216  0,009  AMP-activated protein kinase stimulant
0,208  0,004  Glycine receptor agonist
0,206  0,002  Retinoic acid beta receptor agonist
0,266  0,062  Free radical scavenger
0,208  0,004  Neuraminidase (influenza) inhibitor
0,238  0,036  Antihelmintic (Nematodes)
0,301  0,099  Inflammatory Bowel disease treatment
0,213  0,012  Protein kinase C gamma inhibitor
0,232  0,032  Muscular dystrophy treatment
0,207  0,008  Sphingosine 1-phosphate receptor 4 antagonist
0,205  0,006  Aminopeptidase I inhibitor
0,229  0,031  CNS active muscle relaxant
0,250  0,052  Chemopreventive
0,209  0,011  Photosensitizer
0,212  0,015  Cyclooxygenase 3 inhibitor
0,228  0,031  Cystic fibrosis treatment
0,200  0,003  Glutamate (mGluR3) antagonist
0,239  0,043  I kappa B kinase epsilon inhibitor
0,199  0,003  Glutamate (mGluR6) antagonist
0,222  0,026  Hemostatic
0,198  0,003  Dihydroorotase inhibitor
0,204  0,010  Antiviral (Influenza B)
0,208  0,016  Movement disorders treatment
0,201  0,009  Actinic keratosis treatment
0,194  0,003  Retinoic acid alpha receptor agonist
0,205  0,013  Carbonic anhydrase XIII inhibitor
0,211  0,021  Antineoplastic antimetabolite
0,229  0,039  Diabetic nephropathy treatment
0,210  0,020  Cathepsin H inhibitor
0,194  0,004  Kainate receptor antagonist
0,312  0,124  15-Lipoxygenase inhibitor
0,192  0,004  Hyperparathyroidism treatment
0,207  0,019  Antieczematic
0,191  0,004  Purinergic P2X1 antagonist
0,197  0,011  Glutamate receptor agonist
0,202  0,018  Antischistosomal
0,235  0,051  Antihelmintic
0,218  0,034  VEGF expression inhibitor
0,212  0,028  Antifungal enhancer
0,255  0,071  Urologic disorders treatment
0,224  0,041  Thrombolytic
0,206  0,023  Antitussive
0,220  0,037  Diuretic
0,298  0,115  Calpain 2 inhibitor
0,235  0,052  Sigma receptor agonist
0,183  0,004  Antiviral (Parainfluenza)
0,207  0,027  Catenin beta inhibitor
0,222  0,045  Antiviral (Hepatitis)
0,182  0,004  Plasminogen activator inhibitor antagonist
0,190  0,016  NMDA receptor antagonist
0,221  0,047  Age-related macular degeneration treatment
0,178  0,005  Neuraminidase inhibitor
0,215  0,041  5 Hydroxytryptamine 3E antagonist
0,205  0,032  Phobic disorders treatment
0,210  0,038  Skeletal muscle relaxant
0,235  0,062  Peptidyltransferase inhibitor
0,183  0,011  Protein kinase C delta inhibitor
0,183  0,011  HIV-1 integrase (3'-Processing) inhibitor
0,177  0,008  Ornithine carbamoyltransferase inhibitor
0,201  0,032  Aldose reductase substrate
0,202  0,033  Neurotensin receptor agonist
0,178  0,011  HIV-1 integrase (Strand Transfer) inhibitor
0,181  0,014  Sphingosine 1-phosphate receptor 2 antagonist
0,265  0,098  CYP2D6 substrate
0,192  0,026  Protein kinase (CK2) alpha inhibitor
0,208  0,042  Hair growth stimulant
0,172  0,007  Ornithine decarboxylase inhibitor
0,167  0,003  Retinoic acid receptor agonist
0,186  0,022  Protein kinase (CK2) inhibitor
0,204  0,039  Antiviral (Hepatitis C)
0,168  0,004  D-Ala-D-Ala ligase inhibitor
0,186  0,022  Adenylate cyclase stimulant
0,203  0,040  NOS3 expression enhancer
0,200  0,037  Uterine stimulant
0,247  0,085  Antioxidant
0,179  0,018  Aldehyde dehydrogenase substrate
0,183  0,021  Coagulant
0,165  0,005  Dihydroorotate dehydrogenase inhibitor
0,188  0,028  Cell adhesion inhibitor
0,165  0,006  Xanthine dehydrogenase inhibitor
0,169  0,009  Carbamoyl phosphate synthetase inhibitor
0,196  0,038  Insulin secretagoues
0,195  0,036  NADPH oxidase inhibitor
0,163  0,005  NMDA receptor subunit 3B antagonist
0,165  0,007  Glutamate release inhibitor
0,191  0,034  Cocaine dependence treatment
0,158  0,004  Nicotinic acid receptor agonist
0,172  0,018  Calcium antagonist
0,177  0,023  Menstruation disorders treatment
0,205  0,052  Prostatic (benign) hyperplasia treatment
0,185  0,032  CF transmembrane conductance regulator agonist
0,257  0,105  12-Lipoxygenase inhibitor
0,184  0,032  Toll-Like receptor 2 antagonist
0,153  0,002  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,155  0,005  Granulocyte macrophage colony stimulating factor agonist
0,210  0,060  CYP2B6 inhibitor
0,209  0,060  Hepatoprotectant
0,178  0,028  Chelator
0,190  0,040  Antidiarrheal
0,151  0,003  Retinoid X alpha receptor agonist
0,153  0,004  NMDA receptor glycine site agonist
0,153  0,005  Glutamate (mGluR group III) agonist
0,191  0,043  Anesthetic
0,163  0,015  NAD(P)H dehydrogenase (quinone) inhibitor
0,155  0,007  Antidote, heavy metal
0,207  0,059  Histone acetyltransferase inhibitor
0,192  0,044  Melanin inhibitor
0,174  0,027  Falcipain 3 inhibitor
0,159  0,013  Macrophage migration inhibitory factor inhibitor
0,163  0,018  Urease inhibitor
0,174  0,028  Antiviral (Poxvirus)
0,159  0,013  CC chemokine 6 receptor antagonist
0,148  0,003  Adenine nucleotide translocase inhibitor
0,310  0,165  Apoptosis agonist
0,154  0,010  Potassium channel large-conductance Ca-activated activator
0,216  0,072  Cytotoxic
0,178  0,034  Glutamate receptor antagonist
0,147  0,004  GABA B receptor agonist
0,150  0,007  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,146  0,004  Glutamate (mGluR group III) antagonist
0,146  0,004  Glutamate (mGluR4) antagonist
0,199  0,058  Amyloid beta precursor protein antagonist
0,195  0,053  Antianorexic
0,144  0,003  Antidote, organophosphates
0,173  0,033  Adenylate cyclase inhibitor
0,226  0,085  Vasodilator
0,169  0,028  Endometrios treatment
0,147  0,007  CDC25B inhibitor
0,155  0,015  Anabolic
0,148  0,009  Antifungal (Aspergillus)
0,181  0,042  Antiprotozoal (Coccidial)
0,139  0,001  Vesicular glutamate transport inhibitor
0,196  0,058  LDLR expression enhancer
0,214  0,076  Fibrosis treatment
0,152  0,014  UGT2B11 substrate
0,144  0,007  Anticholelithogenic
0,165  0,028  Nav1.1 sodium channel blocker
0,153  0,017  ABCA1 expression enhancer
0,169  0,033  Antihelmintic (Trematoda)
0,144  0,008  Phosphorylase inhibitor
0,175  0,040  Topoisomerase II inhibitor
0,160  0,025  HDL-cholesterol increasing
0,147  0,013  Glutathione S-transferase inhibitor
0,148  0,013  Peroxisome proliferator-activated receptor gamma agonist
0,146  0,012  Tourette's syndrome treatment
0,142  0,009  Carbonic anhydrase VB inhibitor
0,135  0,003  Retinoid X gamma receptor agonist
0,136  0,003  NMDA 2D receptor antagonist
0,168  0,036  Farnesoid X receptor antagonist
0,153  0,021  Prolactin inhibitor
0,133  0,002  Glutamate (mGluR8) agonist
0,136  0,005  TRPM8 blocker
0,160  0,029  Gastritis treatment
0,146  0,015  Carbonic anhydrase V inhibitor
0,167  0,037  Interleukin 4 antagonist
0,222  0,092  Calpain inhibitor
0,132  0,002  Sodium-dependent vitamin C transporter 2 inhibitor
0,133  0,004  Kainate receptor 5 antagonist
0,134  0,005  Prostaglandin F2 alpha antagonist
0,132  0,004  Glutamate (mGluR7) antagonist
0,133  0,005  NMDA receptor subunit 3A antagonist
0,160  0,033  Interleukin 1b antagonist
0,131  0,004  Prostaglandin EP1 antagonist
0,153  0,026  Caspase 3 inhibitor
0,219  0,092  Aryl hydrocarbon receptor agonist
0,167  0,041  DNA polymerase I inhibitor
0,153  0,027  Sulfotransferase substrate
0,129  0,003  Retinoid X receptor agonist
0,142  0,017  Histamine N-methyltransferase inhibitor
0,143  0,018  Paget's disease treatment
0,175  0,051  Thiol protease inhibitor
0,128  0,004  AMPA 4 receptor antagonist
0,135  0,011  Glycine receptor antagonist
0,151  0,028  Mediator release inhibitor
0,157  0,034  Microtubule formation inhibitor
0,183  0,062  Liver fibrosis treatment
0,123  0,003  GABA uptake inhibitor
0,124  0,004  Kainate receptor 2 antagonist
0,248  0,128  Prostaglandin dehydrogenase inhibitor
0,185  0,065  Muscle relaxant
0,132  0,013  Leukotriene antagonist
0,132  0,012  Bile acid receptor antagonist
0,122  0,003  Kainate receptor 1 antagonist
0,123  0,004  Dihydroorotate oxidase inhibitor
0,202  0,084  Antialcoholic
0,128  0,010  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,213  0,098  Neuropeptide Y2 antagonist
0,213  0,098  Myocardial infarction treatment
0,120  0,004  Antihemophilic
0,130  0,015  Carbonic anhydrase VA inhibitor
0,124  0,009  Estrogen-related receptor beta agonist
0,144  0,028  Chronic obstructive bronchitis treatment
0,285  0,170  DNA directed DNA polymerase inhibitor
0,153  0,039  Growth stimulant
0,193  0,079  Osteoarthritis treatment
0,196  0,082  Psychostimulant
0,123  0,009  Peroxisome proliferator-activated receptor gamma antagonist
0,146  0,033  Anticataract
0,116  0,005  SULT2A1 substrate
0,127  0,017  CDC25A inhibitor
0,214  0,104  DNA damaging
0,115  0,005  Glutamate (mGluR group II) agonist
0,146  0,036  Contraceptive female
0,116  0,007  Topoisomerase II beta inhibitor
0,147  0,039  5-Lipoxygenase inhibitor
0,161  0,053  Alkaline phosphatase inhibitor
0,129  0,021  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,221  0,114  Cardioprotectant
0,109  0,004  Glutamate (mGluR1a) agonist
0,114  0,009  Protein kinase C beta inhibitor
0,120  0,015  HIV-1 integrase inhibitor
0,128  0,023  Glutamate (mGluR7) agonist
0,123  0,019  Prostaglandin-E synthase inhibitor
0,143  0,040  Antiviral (Papilloma)
0,133  0,030  Acetylcholine release stimulant
0,112  0,009  Phospholipase D inhibitor
0,216  0,113  5 Hydroxytryptamine 1E antagonist
0,105  0,002  Retinoic acid beta receptor antagonist
0,133  0,031  Antiprotozoal (Toxoplasma)
0,112  0,010  AMPA receptor antagonist
0,111  0,009  Antimycoplasmal
0,112  0,011  Autotaxin inhibitor
0,197  0,096  Antiviral (HIV)
0,141  0,040  DNA repair enzyme inhibitor
0,118  0,017  Sphingosine 1-phosphate receptor 4 agonist
0,105  0,004  Glucose-6-phosphate isomerase inhibitor
0,126  0,025  Lanosterol 14 alpha demethylase inhibitor
0,140  0,041  Interleukin 8 antagonist
0,277  0,177  DNA polymerase beta inhibitor
0,124  0,024  Antiviral (Trachoma)
0,104  0,006  Glutamate (mGluR2) agonist
0,133  0,035  Beta glucuronidase inhibitor
0,108  0,011  Peroxisome proliferator-activated receptor alpha agonist
0,116  0,019  Glutamate (mGluR) agonist
0,106  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,121  0,025  Adrenaline agonist
0,099  0,003  Retinoic acid alpha receptor antagonist
0,106  0,009  5-Alpha-reductase inhibitor
0,100  0,004  Prostaglandin EP4 antagonist
0,105  0,010  S-adenosyl-L-methionine decarboxylase inhibitor
0,122  0,027  Cathepsin G inhibitor
0,159  0,064  Pulmonary hypertension treatment
0,144  0,050  Alkylator
0,104  0,010  MAP kinase kinase 7 inhibitor
0,147  0,053  Antiprotozoal (Trichomonas)
0,134  0,039  Transcription factor STAT6 inhibitor
0,137  0,043  Alcohol dehydrogenase substrate
0,100  0,007  MDM2 inhibitor
0,192  0,099  Angiogenesis stimulant
0,141  0,048  Vanilloid 1 agonist
0,098  0,005  Lysophosphatidic acid 3 receptor antagonist
0,121  0,028  Interleukin 12 antagonist
0,097  0,004  Neuraminidase (Influenza A) inhibitor
0,145  0,053  Retinoprotector
0,144  0,052  Liver cirrhosis treatment
0,094  0,002  Glutamate (mGluR3) agonist
0,127  0,036  Sphingomyelinase inhibitor
0,095  0,004  Farnesoid X receptor agonist
0,098  0,008  Nicotinic acid receptor 1 agonist
0,100  0,010  Leukotriene B4 antagonist
0,183  0,093  Antiviral (Ebola)
0,183  0,093  MAP kinase kinase 2 inhibitor
0,094  0,004  Kynurenine 3 monooxygenase inhibitor
0,092  0,003  Retinoic acid receptor gamma antagonist
0,168  0,078  Toxic, respiratory center
0,092  0,003  Kainate receptor agonist
0,103  0,015  NMDA 2C receptor antagonist
0,142  0,053  Anesthetic local
0,094  0,005  Urate transporter 1 inhibitor
0,152  0,064  MAP kinase 3 inhibitor
0,098  0,009  Potassium channel intermediate-conductance Ca-activated blocker
0,266  0,178  Alpha-glucosidase inhibitor
0,093  0,005  Factor III inhibitor
0,093  0,005  RNA-directed RNA polymerase inhibitor
0,094  0,006  Anesthetic inhalation
0,091  0,004  Glutamate (mGluR1) agonist
0,095  0,007  Thromboxane synthase inhibitor
0,090  0,003  Retinoic acid receptor antagonist
0,106  0,020  Narcotic antagonist
0,165  0,079  Antipruritic
0,121  0,035  Interleukin 1 beta converting enzyme inhibitor
0,090  0,004  Pregnane X receptor antagonist
0,219  0,133  Antifungal
0,113  0,027  Cell adhesion molecule inhibitor
0,098  0,013  Protein kinase C epsilon inhibitor
0,090  0,005  Ryanodine receptor antagonist
0,110  0,025  Purinergic P2X2 antagonist
0,141  0,056  Antihemorrhagic
0,097  0,012  Thromboxane antagonist
0,109  0,025  Selectin antagonist
0,090  0,007  Mannosidase inhibitor
0,115  0,032  Antiviral (Rhinovirus)
0,085  0,002  Nicotinic acid receptor 2 antagonist
0,087  0,005  Heparanase inhibitor
0,089  0,006  Leukotriene D4 antagonist
0,118  0,036  Antihypermotility
0,096  0,014  NMDA 2A receptor antagonist
0,224  0,142  Antiallergic
0,108  0,026  3C-Like protease (SARS coronavirus) inhibitor
0,164  0,083  Tumour necrosis factor antagonist
0,111  0,030  Antibiotic
0,136  0,055  Antiviral (Hepatitis B)
0,155  0,075  Neuropathy treatment
0,085  0,005  Glutamate (mGluR4) agonist
0,084  0,004  Nerve growth factor antagonist
0,098  0,018  Maillard reaction inhibitor
0,088  0,008  DNA helicase inhibitor
0,158  0,079  Heat shock protein 90 alpha antagonist
0,086  0,008  Adenosine deaminase inhibitor
0,091  0,013  Carbonic anhydrase XIV inhibitor
0,116  0,038  MAP kinase kinase 1 inhibitor
0,100  0,022  Protein kinase C alpha inhibitor
0,088  0,011  Thromboxane A2 antagonist
0,091  0,014  Exportin-1 inhibitor
0,119  0,043  Gastric antisecretory
0,109  0,033  Restless leg syndrome treatment
0,087  0,011  Nicotinic alpha3beta2 receptor antagonist
0,171  0,095  Ca2+/calmodulin-dependent protein kinase inhibitor
0,135  0,059  Nav1.3 sodium channel blocker
0,078  0,003  Guanylate cyclase inhibitor
0,081  0,006  Dihydropteroate synthase inhibitor
0,080  0,006  5-Alpha-reductase 2 inhibitor
0,084  0,010  Alpha-mannosidase inhibitor
0,079  0,005  5-Alpha-reductase 1 inhibitor
0,184  0,111  Antiamyloidogenic
0,131  0,057  Antiprotozoal (Amoeba)
0,076  0,004  Protein kinase (CK2) beta inhibitor
0,080  0,008  Carnitine palmitoyltransferase 1B inhibitor
0,079  0,007  AMPA 1 receptor antagonist
0,103  0,031  Myeloperoxidase inhibitor
0,080  0,008  Leukotriene C antagonist
0,075  0,004  Glutamate (mGluR8) antagonist
0,111  0,039  Protein kinase C zeta inhibitor
0,097  0,026  Calcium channel L-type blocker
0,074  0,004  Angiotensin II receptor antagonist
0,076  0,006  HCV NS5B polymerase inhibitor
0,074  0,004  Protein kinase C beta II inhibitor
0,074  0,005  Methionyl aminopeptidase 2 inhibitor
0,073  0,004  Retinoid X receptor antagonist
0,073  0,004  Uridine phosphorylase inhibitor
0,082  0,013  Diacylglycerol O-acyltransferase inhibitor
0,114  0,046  Factor V inhibitor
0,094  0,026  Sphingosine 1-phosphate receptor antagonist
0,107  0,040  Phosphodiesterase 6D inhibitor
0,071  0,004  Calcium-sensing receptor agonist
0,098  0,031  Interferon agonist
0,102  0,035  Contraceptive male
0,082  0,016  Sphingosine 1-phosphate receptor 3 antagonist
0,076  0,009  Fructose-1,6-bisphosphatase inhibitor
0,140  0,074  Pregnane X receptor agonist
0,091  0,025  Vanilloid 4 agonist
0,132  0,065  Antibacterial (Helicobacter pylori)
0,099  0,033  NMDA 2 receptor antagonist
0,123  0,057  Shock treatment
0,090  0,025  Antitreponemal
0,098  0,033  Na+ K+ transporting ATPase inhibitor
0,069  0,004  Angiotensin AT1 receptor antagonist
0,072  0,007  Dopamine beta hydroxylase inhibitor
0,102  0,037  Antileprosy
0,072  0,007  Arginase inhibitor
0,072  0,007  Geranyltranstransferase inhibitor
0,072  0,008  Dopamine D5 agonist
0,094  0,030  SULT1A2 substrate
0,077  0,013  Purinergic P2Y antagonist
0,068  0,005  AMPA 3 receptor antagonist
0,073  0,009  AICAR transformylase inhibitor
0,128  0,065  M18 aspartyl aminopeptidase inhibitor
0,070  0,007  Angiotensin AT2 receptor antagonist
0,070  0,007  Membrane dipeptidase inhibitor
0,067  0,004  GABA transporter 3 inhibitor
0,084  0,022  Androgen agonist
0,116  0,055  Mental retardation treatment
0,132  0,071  Nav1.2 sodium channel blocker
0,063  0,002  Glutamate (mGluR6) agonist
0,065  0,005  Liver X receptor beta antagonist
0,141  0,080  Neuropeptide Y1 antagonist
0,085  0,025  Endocannabinoid uptake inhibitor
0,084  0,024  DNA gyrase inhibitor
0,064  0,004  Prostaglandin EP4 agonist
0,070  0,011  Immunoglobulin Fc receptor antagonist
0,130  0,071  Cyclooxygenase 1 inhibitor
0,063  0,004  Retinoid X alpha receptor antagonist
0,062  0,003  Protein kinase C beta I inhibitor
0,063  0,005  Free fatty acid receptor 1 antagonist
0,094  0,036  Nicotinic alpha4beta2 receptor antagonist
0,099  0,042  Interleukin 5 antagonist
0,062  0,005  Leukotriene B4 receptor 1 antagonist
0,061  0,005  LFA antagonist
0,102  0,045  Androgen antagonist
0,063  0,006  Integrin alpha2 antagonist
0,068  0,012  Sphingosine 1-phosphate receptor agonist
0,069  0,012  Thymidylate synthase inhibitor
0,140  0,084  MAP kinase kinase 4 inhibitor
0,068  0,012  Leukotriene A4 hydrolase inhibitor
0,131  0,075  Interleukin 1 antagonist
0,075  0,020  Calcium channel P-type blocker
0,075  0,019  Heme oxygenase stimulant
0,079  0,024  Interferon inducer
0,061  0,007  Peroxisome proliferator-activated receptor alpha antagonist
0,134  0,080  Lipid peroxidase inhibitor
0,071  0,018  Sphingosine 1-phosphate receptor 1 antagonist
0,094  0,041  mTOR complex 2 inhibitor
0,062  0,009  AMPA 2 receptor antagonist
0,056  0,003  Retinoic acid gamma receptor agonist
0,080  0,027  Protease 3C (Human rhinovirus) inhibitor
0,062  0,010  Somatostatin 5 antagonist
0,066  0,014  Adenylate cyclase 1 inhibitor
0,056  0,004  Tryptophan 5 hydroxylase inhibitor
0,191  0,140  Antineurogenic pain
0,067  0,016  Squalene epoxidase inhibitor
0,062  0,011  Phosphoglycerate kinase inhibitor
0,053  0,003  Nicotinic acid receptor 1 antagonist
0,068  0,018  Sphingosine 1-phosphate receptor 5 agonist
0,059  0,009  Endothelin receptor antagonist
0,113  0,062  5 Hydroxytryptamine 3A agonist
0,128  0,078  Bone formation stimulant
0,056  0,006  ATP citrate lysase inhibitor
0,058  0,009  Prostaglandin agonist
0,066  0,016  Carbonic anhydrase VII inhibitor
0,113  0,064  Myasthenia Gravis treatment
0,053  0,004  Antibiotic Naphthyridine-like
0,130  0,081  Neurotrophic factor
0,053  0,004  Leukotriene B4 receptor 2 antagonist
0,098  0,050  Thioredoxin inhibitor
0,055  0,007  Leukotriene C4 antagonist
0,066  0,018  Glutamate (mGluR group I) agonist
0,089  0,042  CYP2A6 inhibitor
0,077  0,030  Beta adrenoreceptor antagonist
0,085  0,038  Epoxide hydrolase inhibitor
0,055  0,008  GABA transporter 2 inhibitor
0,052  0,005  Epoxide hydrolase 1 inhibitor
0,122  0,076  Antismoking
0,200  0,154  Metabolic disease treatment
0,050  0,003  GABA transporter inhibitor
0,052  0,005  NMDA receptor glycine site antagonist
0,053  0,006  Kainate receptor 4 antagonist
0,051  0,005  Prostaglandin EP2 agonist
0,074  0,029  Carbonic anhydrase stimulant
0,051  0,006  Methionyl aminopeptidase 1 inhibitor
0,047  0,003  Retinoid X beta receptor antagonist
0,051  0,008  CF transmembrane conductance regulator antagonist
0,058  0,014  Sphingosine 1-phosphate receptor 1 agonist
0,057  0,014  GABA B receptor antagonist
0,073  0,030  Collagenase 3 inhibitor
0,056  0,013  DNA gyrase subunit A inhibitor
0,051  0,008  Carnitine palmitoyltransferase inhibitor
0,051  0,009  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,057  0,014  Liver X receptor alpha agonist
0,047  0,005  Integrin alpha2beta1 antagonist
0,055  0,013  Squalene synthetase inhibitor
0,055  0,013  Acid-sensing ion channel blocker
0,065  0,023  Factor IXa inhibitor
0,050  0,008  Carnitine palmitoyltransferase 1 inhibitor
0,060  0,019  Aldosterone antagonist
0,057  0,015  Guanylate cyclase stimulant
0,087  0,046  Caspase 7 inhibitor
0,044  0,003  Vanilloid 2 agonist
0,045  0,004  Retinoid X gamma receptor antagonist
0,067  0,026  Beta 2 adrenoreceptor agonist
0,045  0,004  Prostaglandin H2 antagonist
0,143  0,103  Hearing loss treatment
0,132  0,093  Acetylcholine M1 receptor antagonist
0,086  0,046  CC chemokine 5 receptor agonist
0,147  0,108  Sedative
0,066  0,026  Postcoital contraceptive
0,090  0,050  Hematopoietic
0,053  0,014  Beta adrenoreceptor agonist
0,058  0,019  Leukocyte elastase inhibitor
0,062  0,023  Bombesin 2 receptor antagonist
0,048  0,009  Lysophosphatidic acid 2 receptor antagonist
0,042  0,003  Neuraminidase (Influenza B) inhibitor
0,051  0,013  Prostacyclin antagonist
0,044  0,006  Calcium-independent phospholipase A2 inhibitor
0,188  0,150  Antiepileptic
0,043  0,005  Lysophosphatidic acid receptor 1 agonist
0,041  0,003  Carbonic anhydrase VIII inhibitor
0,041  0,003  Carbonic anhydrase X inhibitor
0,042  0,004  Lysophosphatidic acid 1 receptor antagonist
0,090  0,053  Tocolytic
0,061  0,024  Prolyl endopeptidase inhibitor
0,051  0,015  Glutamate (mGluR group II) antagonist
0,052  0,015  Alpha 1d adrenoreceptor agonist
0,121  0,085  Skin whitener
0,054  0,018  Glutamate (mGluR1a) antagonist
0,052  0,016  Dihydrofolate reductase inhibitor
0,060  0,024  Glucose-6-phosphate translocase inhibitor
0,070  0,034  Beta 3 adrenoreceptor antagonist
0,042  0,007  Protocollagen prolyl hydroxylase inhibitor
0,046  0,011  Peroxisome proliferator-activated receptor delta antagonist
0,073  0,038  Carbonic anhydrase inhibitor
0,083  0,048  Somatostatin 1 agonist
0,067  0,033  Glutamate (mGluR1) antagonist
0,046  0,011  Liver X receptor antagonist
0,075  0,041  Dysmenorrhea treatment
0,043  0,009  Lysine carboxypeptidase inhibitor
0,070  0,036  Antiemphysemic
0,038  0,005  Kainate receptor 3 antagonist
0,041  0,007  Prostaglandin E2 agonist
0,139  0,106  Nitric oxide antagonist
0,055  0,022  Cholesterol esterase inhibitor
0,037  0,004  Antibiotic Quinolone-like
0,038  0,005  GRP78 expression inhibitor
0,061  0,029  Angiotensin-converting enzyme inhibitor
0,041  0,009  Liver X receptor alpha antagonist
0,086  0,054  Histamine H2 receptor antagonist
0,043  0,011  Cholesterol ester transfer protein antagonist
0,035  0,003  Egl nine homolog 3 inhibitor
0,060  0,029  Myc inhibitor
0,045  0,014  Peroxisome proliferator-activated receptor delta agonist
0,050  0,019  Factor XIa inhibitor
0,066  0,035  Carbonic anhydrase IX inhibitor
0,046  0,015  Cholesterol absorption inhibitor
0,037  0,007  Estrogen-related receptor gamma antagonist
0,063  0,033  Carbonic anhydrase I inhibitor
0,066  0,037  Transcription factor RelA inhibitor
0,053  0,023  Glutamate (mGluR5) agonist
0,061  0,032  CC chemokine 2 receptor antagonist
0,122  0,094  Pancreatic disorders treatment
0,041  0,012  Prostaglandin D2 agonist
0,079  0,050  Estrogen receptor alpha antagonist
0,046  0,017  Diamine oxidase inhibitor
0,084  0,055  Antiprotozoal activity enhancer
0,065  0,037  Phosphodiesterase 1C inhibitor
0,086  0,058  Transcription factor NF kappa B stimulant
0,032  0,004  Angiotensin AT1B receptor antagonist
0,167  0,140  Heart failure treatment
0,088  0,061  Aminoacyl-tRNA synthetase inhibitor
0,030  0,003  GABA transporter 1 inhibitor
0,046  0,019  Heme oxygenase inhibitor
0,031  0,004  Egl nine homolog 1 inhibitor
0,032  0,005  Angiotensin AT1A receptor antagonist
0,035  0,008  Excitatory amino acid transporter 2 inhibitor
0,039  0,013  Hypoxanthine phosphoribosyltransferase inhibitor
0,050  0,024  Carbonic anhydrase IV inhibitor
0,053  0,027  Antiviral (Herpesvirus 3, Human)
0,068  0,042  Uterine relaxant
0,041  0,015  Purinergic P2Y2 antagonist
0,059  0,033  Sphingosine kinase 2 inhibitor
0,052  0,027  Potassium channel Kv1.3 blocker
0,094  0,069  Antifungal (Candida)
0,074  0,049  Potassium channel (Tandem pore domain) blocker
0,051  0,026  Oleamide hydrolase inhibitor
0,040  0,015  Liver X receptor beta agonist
0,049  0,025  Purinergic P2X4 antagonist
0,105  0,081  Proteasome inhibitor
0,145  0,122  Interleukin antagonist
0,031  0,008  Beta 1 adrenoreceptor agonist
0,046  0,023  Thymidine kinase inhibitor
0,174  0,151  Streptokinase A inhibitor
0,026  0,003  Methylmalonyl-CoA mutase inhibitor
0,030  0,008  Protease (Human cytomegalovirus) inhibitor
0,062  0,040  TRPA1 antagonist
0,063  0,040  Transcription factor AP-1 inhibitor
0,030  0,009  Prostaglandin F2 alpha agonist
0,078  0,056  Chymotrypsin inhibitor
0,041  0,019  Vanilloid 3 antagonist
0,026  0,005  CXC chemokine 5 receptor antagonist
0,033  0,012  CXC chemokine 2 receptor antagonist
0,085  0,064  Bromodomain-containing protein 2 inhibitor
0,030  0,009  Endothelin B receptor antagonist
0,027  0,006  G-protein-coupled receptor 120 agonist
0,028  0,008  Monocarboxylic acid transporter 1 inhibitor
0,028  0,008  Monocarboxylic acid transporter inhibitor
0,063  0,043  Nitric oxide donor
0,051  0,031  HCV NS3/NS4A protease inhibitor
0,055  0,035  Carbonic anhydrase XII inhibitor
0,034  0,014  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,033  0,013  Purinergic P2Y15 antagonist
0,029  0,009  Complement factor 1s inhibitor
0,056  0,036  Glucosylceramidase inhibitor
0,059  0,040  Sphingosine kinase inhibitor
0,024  0,004  Lysophosphatidic acid receptor 3 agonist
0,021  0,002  Mannitol 2-dehydrogenase inhibitor
0,055  0,037  Epithelial sodium channel blocker
0,056  0,038  Carbonic anhydrase II inhibitor
0,064  0,046  Neutrophil collagenase inhibitor
0,057  0,039  Fatty acid synthase inhibitor
0,036  0,018  Nucleoside transporters inhibitor
0,124  0,106  MAP3K9 inhibitor
0,050  0,032  Antimetabolite
0,025  0,008  Aminopeptidase A inhibitor
0,025  0,008  Excitatory amino acid transporter 3 inhibitor
0,030  0,013  Hedgehog signaling activator
0,026  0,009  Isoleucine-tRNA ligase inhibitor
0,086  0,070  Polo-like kinase-1 inhibitor
0,077  0,061  Histamine H1 receptor antagonist
0,036  0,020  Factor XI inhibitor
0,026  0,010  ICAM 1 antagonist
0,032  0,016  Carnitine palmitoyltransferase 1A inhibitor
0,021  0,005  Thromboxane A2 agonist
0,035  0,019  Carboxypeptidase B inhibitor
0,027  0,011  Fructose-1,6-bisphosphatase 1 inhibitor
0,039  0,024  DNA gyrase subunit B inhibitor
0,175  0,160  CYP1A2 inhibitor
0,047  0,032  Benzodiazepine antagonist
0,051  0,036  Beta 2 adrenoreceptor antagonist
0,079  0,064  Thioredoxin reductase inhibitor
0,021  0,007  Telomerase stimulant
0,018  0,004  Carbonic anhydrase XI inhibitor
0,019  0,005  Human herpes virus 5 capsid protein P40 inhibitor
0,028  0,014  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,067  0,054  Amidase inhibitor
0,034  0,021  Catechol O-methyltransferase inhibitor
0,022  0,008  Antibiotic Anthracycline-like
0,065  0,053  Gaucher disease treatment
0,021  0,008  Calcium-sensing receptor antagonist
0,031  0,019  Glutamate (mGluR2) antagonist
0,017  0,004  Thromboxane agonist
0,042  0,030  Oxytocin agonist
0,034  0,022  Melatonin receptor 1A agonist
0,027  0,016  Thyroid hormone agonist
0,027  0,016  Thymidine phosphorylase inhibitor
0,016  0,005  Thrombopoietin agonist
0,082  0,072  Potassium channel activator
0,031  0,020  Prostaglandin EP3 antagonist
0,023  0,013  Endothelin A receptor antagonist
0,067  0,057  Bulimia treatment
0,049  0,039  Potassium channel (Inward rectifier) activator
0,121  0,111  Anticoagulant
0,015  0,006  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,102  0,093  Estrogen antagonist
0,019  0,010  Complement factor D inhibitor
0,047  0,038  Cytokine production stimulant
0,182  0,173  Bone diseases treatment
0,046  0,037  Potassium channel (ATP-sensitive) activator
0,023  0,014  Bombesin agonist
0,021  0,012  Caspase 8 inhibitor
0,012  0,004  Folate transporter 1 inhibitor
0,017  0,009  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,042  0,034  Histamine H1 receptor agonist
0,219  0,210  Transcription factor inhibitor
0,035  0,027  Ceramide glucosyltransferase inhibitor
0,101  0,093  MAP kinase kinase inhibitor
0,021  0,013  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,019  0,012  Estrogen-related receptor gamma agonist
0,019  0,012  Bombesin 3 receptor agonist
0,054  0,048  Botulinum neurotoxin type A inhibitor
0,014  0,007  Integrin beta2 antagonist
0,051  0,045  Beta 1 adrenoreceptor antagonist
0,113  0,107  Antiischemic, cerebral
0,048  0,042  Ribonucleoside-diphosphate reductase inhibitor
0,037  0,032  Toll-Like receptor 2 agonist
0,038  0,033  Estradiol 17 beta-dehydrogenase inhibitor
0,019  0,014  Vesicular acetylcholine transporter inhibitor
0,068  0,063  Adenosine A3 receptor antagonist
0,047  0,042  Aldose reductase inhibitor
0,048  0,044  Ribonucleotide reductase inhibitor
0,008  0,003  Insulin like growth factor 3 antagonist
0,025  0,021  Sodium/glucose cotransporter 2 inhibitor
0,144  0,140  Focal adhesion kinase 2 inhibitor
0,008  0,005  DNA topoisomerase III inhibitor
0,059  0,057  Acetylcholine M5 receptor agonist
0,011  0,008  Beta 3 adrenoreceptor agonist
0,037  0,035  Glucagon-like peptide 1 receptor antagonist
0,006  0,005  Integrin alpha5beta6 antagonist
0,039  0,038  Nicotinic receptor alpha3 subunit antagonist
0,014  0,013  Purinergic P2Y1 agonist
0,004  0,003  Antibiotic Carbapenem-like
0,122  0,122  Antifungal (Cryptococcus)
0,029  0,028  Calcitonin receptor agonist
0,056  0,056  5 Hydroxytryptamine 3 agonist
0,071  0,070  Xanthine oxidase substrate
0,057  0,057  Trypsin inhibitor
0,016  0,015  CC chemokine 9 receptor antagonist
0,118  0,118  Heat shock protein 90 antagonist
0,071  0,070  Protein kinase A inhibitor
0,028  0,028  Estradiol 17 beta-dehydrogenase 3 inhibitor

